A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

DUI

D014229 MeSH Browser

CUI

M0021910

CAS

4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-(2-chlorophenyl)-1-methyl-

Previous indexing

Benzazepines (1974); Benzodiazepines (1975-1976); Triazoles (1974-1976)

History note

86(77); was see under BENZODIAZEPINE TRANQUILIZERS 1977-85

Public note

86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85